Medical Devices & Tech

LoneStar Heart

26051 Merit Circle, Suite 104
Laguna Hills, CA 92653 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Therapies to preserve and restore adequate heart function in patients with Congestive Heart Failure (CHF).

Management Frank Ahmann, President & Chief Operating Officer; Sam Helgerson, Ph.D., Chief Technology Officer; Andy G. Hinson, Vice President, Clinical and Regulatory Affairs

Click here for Financial Data
Keywords: LoneStar Heart, Inc, CardioPolymers, Cardiology, Congestive Heart Failure, CHF, lone star heart


Updated: Sept. 03, 2014


LoneStar Heart Inc. is a biomedical company developing new therapies for patients with Congestive Heart Failure (CHF), a condition that is becoming increasingly frequent in developed countries and whi......view more

Products / Services

Products are classified as medical devices and the Company's lead product, Algisyl-LVR, is designed to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation, condi......view more

Technology / Differentiation

The Algisyl-LVR technology involves implanting a space-occupying biocompatible polymer into strategic areas of the heart's left ventricle (LV) wall to affect LV shape and prevent or reverse LV enlarge...view more

Market / Customers

The initial market for the product is $650 mill for use in NYHA Class III patients undergoing concomitant heart surgery with a target market of 300,000 patients in U.S. and W. Europe. The second gener......view more


Algisyl-LVR has been extensively tested in pre-clinical models for over two years to establish its mode of action, safety, efficacy and tolerability. Algisyl-LVR has advanced to human clinical studies...view more